WELLINGTON MANAGEMENT GROUP LLP 13D/13G Filings for Freeline Therapeutics Holdings plc (FRLN)

WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Freeline Therapeutics Holdings plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-04
09:06 am
Sale
2021-12-3113GFreeline Therapeutics Holdings plc
FRLN
WELLINGTON MANAGEMENT GROUP LLP29,320
1.230%
-91,613decrease
(-75.76%)
Filing
2021-08-10
07:57 am
Sale
2021-07-3013GFreeline Therapeutics Holdings plc
FRLN
WELLINGTON MANAGEMENT GROUP LLP120,932
5.060%
-113,840decrease
(-48.49%)
Filing
2021-01-11
09:10 am
Purchase
2020-12-3113GFreeline Therapeutics Holdings plc
FRLN
WELLINGTON MANAGEMENT GROUP LLP234,772
10.600%
234,772increase
(New Position)
Filing